Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Miscellaneous
  4. Linking out to clinical trial publications in a neutral manner
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Linking out to clinical trial publications in a neutral manner

Scheduled Pinned Locked Moved Miscellaneous
5 Posts 2 Posters 373 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • K Offline
    K Offline
    kshulist
    wrote on last edited by
    #1

    Hi there,
    In general, can we use branded emails with no claims to link out to clinical trial publications (not included in the PM) that may not pass PAAB's requirements to support efficacy/safety claims (though we are not using the publications to support any claims)?

    It might be easier to explain my question with an example:

    I understand that to support comparative efficacy and safety claims, publications need to be head-to-head, well-designed, adequately controlled, blinded, randomized. However, let's say we have an open-label H2H (due to different administrations of the drugs) that is not included in the PM. Could we develop a branded email that only says "There was a head-to-head study done" and provides a link to the publication (without any claims at all)?

    Or a similar example is for an RTE publication. Let's say the RTE publication would not meet the recently updated PAAB requirements to support efficacy/safety claims. Could we still neutrally link out to it from a branded email ("See a link to recent real world data below")?

    Thank you for your help!

    Jennifer CarrollJ 1 Reply Last reply
    0
    • K kshulist

      Hi there,
      In general, can we use branded emails with no claims to link out to clinical trial publications (not included in the PM) that may not pass PAAB's requirements to support efficacy/safety claims (though we are not using the publications to support any claims)?

      It might be easier to explain my question with an example:

      I understand that to support comparative efficacy and safety claims, publications need to be head-to-head, well-designed, adequately controlled, blinded, randomized. However, let's say we have an open-label H2H (due to different administrations of the drugs) that is not included in the PM. Could we develop a branded email that only says "There was a head-to-head study done" and provides a link to the publication (without any claims at all)?

      Or a similar example is for an RTE publication. Let's say the RTE publication would not meet the recently updated PAAB requirements to support efficacy/safety claims. Could we still neutrally link out to it from a branded email ("See a link to recent real world data below")?

      Thank you for your help!

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Hi @kshulist

      Generally, as per PAAB code sections 3.1.1 and 5.7, an APS should not link to a clinical trial paper/publication that does not meet the PAAB criteria for comparative clinical claims and is not featured in the TMA. This includes a neutral presentation that only mentions the study and makes no claims.

      For the second example, we understood the "RTE" publication to be “RWE" publication. For RWE studies, the same principle applies. Should the RWE publication not meet the requirements of the RWE document, there should be no linking to such a study from a branded email/other branded APS.

      K 2 Replies Last reply
      0
      • Jennifer CarrollJ Jennifer Carroll

        Hi @kshulist

        Generally, as per PAAB code sections 3.1.1 and 5.7, an APS should not link to a clinical trial paper/publication that does not meet the PAAB criteria for comparative clinical claims and is not featured in the TMA. This includes a neutral presentation that only mentions the study and makes no claims.

        For the second example, we understood the "RTE" publication to be “RWE" publication. For RWE studies, the same principle applies. Should the RWE publication not meet the requirements of the RWE document, there should be no linking to such a study from a branded email/other branded APS.

        K Offline
        K Offline
        kshulist
        wrote on last edited by
        #3

        @jennifer-carroll Thanks Jennifer!

        1 Reply Last reply
        0
        • Jennifer CarrollJ Jennifer Carroll

          Hi @kshulist

          Generally, as per PAAB code sections 3.1.1 and 5.7, an APS should not link to a clinical trial paper/publication that does not meet the PAAB criteria for comparative clinical claims and is not featured in the TMA. This includes a neutral presentation that only mentions the study and makes no claims.

          For the second example, we understood the "RTE" publication to be “RWE" publication. For RWE studies, the same principle applies. Should the RWE publication not meet the requirements of the RWE document, there should be no linking to such a study from a branded email/other branded APS.

          K Offline
          K Offline
          kshulist
          wrote on last edited by
          #4

          @jennifer-carroll, I had a follow-up question. Would it be okay to link to publications that do not meet the PAAB criteria from an unbranded email? Thank you!

          Jennifer CarrollJ 1 Reply Last reply
          0
          • K kshulist

            @jennifer-carroll, I had a follow-up question. Would it be okay to link to publications that do not meet the PAAB criteria from an unbranded email? Thank you!

            Jennifer CarrollJ Offline
            Jennifer CarrollJ Offline
            Jennifer Carroll
            wrote on last edited by
            #5

            @kshulist

            No, it would not be acceptable to include a study that does not meet PAAB requirements for evidence in branded or unbranded APS. Please note that in general, a study for the sponsor's product would not be considered unbranded, even without the brand name or branding elements.

            1 Reply Last reply
            0
            Reply
            • Reply as topic
            Log in to reply
            • Oldest to Newest
            • Newest to Oldest
            • Most Votes


            • Login

            • Don't have an account? Register

            • Login or register to search.
            • First post
              Last post
            0
            • Categories
            • Recent
            • Tags
            • Popular
            • Users
            • Groups